Literature DB >> 16756729

Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesity.

Gerit-Holger Schernthaner1, Hans-Peter Kopp, Stefan Kriwanek, Katarzyna Krzyzanowska, Miriam Satler, Renate Koppensteiner, Guntram Schernthaner.   

Abstract

BACKGROUND: Morbid obesity is associated with insulin resistance (IR), chronic inflammation and premature atherosclerosis. Since vascular inflammation may contribute to the increased risk of cardiovascular morbidity and mortality of these patients, we studied circulating Interleukin-18 (L-18) and monocyte-chemoattractant-protein-1 (MCP-1) levels in 37 patients with morbid obesity before and after significant weight loss induced by bariatric surgery and their preoperative and postoperative associations with C-reactive protein (CRP) and IR-associated factors.
METHODS: High sensitivity assays were used to measure concentrations of fasting CRP, IL-18 and MCP-1. Differences between patients before and after bariatric surgery were analyzed by Student's paired t-test. To investigate the associations of the observed reductions of values, delta of parameters were calculated and preoperative, postoperative and delta data were tested by univariate and multivariate linear regression.
RESULTS: After a mean follow-up period of 26.5 months and a massive weight loss of 35 kg induced by bariatric surgery, circulating IL-18 levels decreased by 37% (P<0.001) and circulating MCP-1 levels by 47% (P<0.001). Multiple linear regression of delta values of IL-18 showed that only 2-hour glucose (P=0.008) remained independently and significantly associated with IL-18, whereas multiple linear regression analysis of delta values of MCP-1 revealed that only delta of HOMA-IR (P<0.001) remained independently and significantly associated with MCP-1, respectively.
CONCLUSIONS: Because both biomarkers have been shown to play an important role in the development and progression of atherosclerosis, the observations presented in this study could be of clinical relevance for morbidly obese patients undergoing bariatric surgery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16756729     DOI: 10.1381/096089206777346763

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  28 in total

Review 1.  Reductions in cardiovascular risk after bariatric surgery.

Authors:  Fethi Benraouane; Sheldon E Litwin
Journal:  Curr Opin Cardiol       Date:  2011-11       Impact factor: 2.161

2.  Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Attenuate Pro-inflammatory Small Intestinal Cytokine Signatures.

Authors:  Renuka Subramaniam; Hassan Aliakbarian; Hina Y Bhutta; David A Harris; Ali Tavakkoli; Eric G Sheu
Journal:  Obes Surg       Date:  2019-12       Impact factor: 4.129

3.  Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency.

Authors:  Eric P Zorrilla; Manuel Sanchez-Alavez; Shuei Sugama; Molly Brennan; Rosette Fernandez; Tamas Bartfai; Bruno Conti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

4.  Early Effects of Sleeve Gastrectomy on Obesity-Related Cytokines and Bile Acid Metabolism in Morbidly Obese Japanese Patients.

Authors:  Hideharu Shimizu; Fumihiko Hatao; Kazuhiro Imamura; Kijuro Takanishi; Motoyoshi Tsujino
Journal:  Obes Surg       Date:  2017-12       Impact factor: 4.129

5.  Increase of osteopontin plasma concentrations after bariatric surgery independent from inflammation and insulin resistance.

Authors:  Georg Schaller; Yoshimasa Aso; Gerit-Holger Schernthaner; Hans-Peter Kopp; Toshihiko Inukai; Stefan Kriwanek; Guntram Schernthaner
Journal:  Obes Surg       Date:  2008-05-02       Impact factor: 4.129

6.  Parameters of inflammation in morbid obesity: lack of effect of moderate weight loss.

Authors:  Eva Solá; Ana Jover; Antonio López-Ruiz; María Jarabo; Amparo Vayá; Carlos Morillas; Marcelino Gómez-Balaguer; Antonio Hernández-Mijares
Journal:  Obes Surg       Date:  2008-12-03       Impact factor: 4.129

Review 7.  Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review.

Authors:  John N Fain
Journal:  Mediators Inflamm       Date:  2010-05-23       Impact factor: 4.711

Review 8.  Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients.

Authors:  Konstantinos Tziomalos; Hariklia V Dimitroula; Niki Katsiki; Christos Savopoulos; Apostolos I Hatzitolios
Journal:  Mediators Inflamm       Date:  2010-03-07       Impact factor: 4.711

Review 9.  The impact of bariatric surgery on inflammation: quenching the fire of obesity?

Authors:  Samar Hafida; Tooraj Mirshahi; Barbara S Nikolajczyk
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-10       Impact factor: 3.243

Review 10.  Biomarkers of obesity and subsequent cardiovascular events.

Authors:  Salma Musaad; Erin N Haynes
Journal:  Epidemiol Rev       Date:  2007-05-10       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.